(1)
Bos, V.; Crouwel, F.; Waaijenberg, P.; Bouma, G.; Duijvestein, M.; Buiter, H.; Brand, H.; Hamer, H.; de Boer, N. Salivary Calprotectin Is Not a Useful Biomarker to Monitor Disease Activity in Patients With Inflammatory Bowel Disease. JGLD 2022, 31, 283-289.